Hosted on MSN
Q4 Earnings Outperformers: 10x Genomics (NASDAQ:TXG) And The Rest Of The Life Sciences Tools & Services Stocks
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the life sciences tools & services industry, including 10x Genomics (NASDAQ:TXG) and its peers. The life ...
PLEASANTON, Calif., Feb. 23, 2025 /PRNewswire/ -- At the Advances in Genome Biology and Technology (AGBT) General Meeting, 10x Genomics, Inc., a leader in single cell and spatial biology, announced a ...
8 analysts have shared their evaluations of 10x Genomics (NASDAQ:TXG) during the recent three months, expressing a mix of bullish and bearish perspectives. The table below summarizes their recent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results